SI
TAK icon

Stephens Inc’s Takeda Pharmaceutical TAK Stock Holding History

Stephens Inc’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,317
Closed -$235K – 1410
2021
Q3 		$235K Buy
14,317
+3,618
+34% +$60.7K ﹤0.01% 1151
2021
Q2 		$180K Buy
+10,699
New +$182K ﹤0.01% 1220
2020
Q4 		– Sell
-10,675
Closed -$190K – 1266
2020
Q3 		$190K Sell
10,675
-1,967
-16% -$35.8K ﹤0.01% 1035
2020
Q2 		$227K Sell
12,642
-410
-3% -$7.36K ﹤0.01% 932
2020
Q1 		$198K Buy
13,052
+2,211
+20% +$40.1K 0.01% 893
2019
Q4 		$214K Sell
10,841
-863
-7% -$16.5K ﹤0.01% 995
2019
Q3 		$201K Buy
11,704
+732
+7% +$12.7K ﹤0.01% 1051
2019
Q2 		$194K Buy
+10,972
New +$200K ﹤0.01% 1074

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc's TAK Position: Q4 2021 in Review

Stephens Inc sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 14,317 shares — an estimated $235K sold.

Stephens Inc first reported a position in TAK in Q2 2019 and held it in 8 quarters. The position peaked at $235K in Q3 2021. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

  • Stephens Inc reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • Stephens Inc sold 14,317 Takeda Pharmaceutical shares in Q4 2021, an estimated $235K.
  • Stephens Inc first reported a position in Takeda Pharmaceutical in Q2 2019 and held it in 8 quarters.
  • Stephens Inc's Takeda Pharmaceutical position peaked at $235K in Q3 2021.
  • 298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Stephens Inc's 13F filing for Q4 2021, filed 7 Mar 2022.